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Allan-Herndon-Dudley syndrome was among the first of the X-linked mental retardation syndromes to be described
(in 1944) and among the first to be regionally mapped on the X chromosome (in 1990). Six large families with
the syndrome have been identified, and linkage studies have placed the gene locus in Xq13.2. Mutations in the
monocarboxylate transporter 8 gene (MCT8) have been found in each of the six families. One essential function
of the protein encoded by this gene appears to be the transport of triiodothyronine into neurons. Abnormal
transporter function is reflected in elevated free triiodothyronine and lowered free thyroxine levels in the blood.
Infancy and childhood in the Allan-Herndon-Dudley syndrome are marked by hypotonia, weakness, reduced muscle
mass, and delay of developmental milestones. Facial manifestations are not distinctive, but the face tends to be
elongated with bifrontal narrowing, and the ears are often simply formed or cupped. Some patients have myopathic
facies. Generalized weakness is manifested by excessive drooling, forward positioning of the head and neck, failure
to ambulate independently, or ataxia in those who do ambulate. Speech is dysarthric or absent altogether. Hypotonia
gives way in adult life to spasticity. The hands exhibit dystonic and athetoid posturing and fisting. Cognitive
development is severely impaired. No major malformations occur, intrauterine growth is not impaired, and head
circumference and genital development are usually normal. Behavior tends to be passive, with little evidence of
aggressive or disruptive behavior. Although clinical signs of thyroid dysfunction are usually absent in affected males,
the disturbances in blood levels of thyroid hormones suggest the possibility of systematic detection through screening
of high-risk populations.
Introduction
Progress in the identification of genes and gene loci on
the X chromosome that are responsible for mental re-
tardation has greatly outpaced the search for autosomal
genes that cause mental retardation. This is a result, in
great part, of the power of hemizygosity of the X chro-
mosome in males to clinically expose gene defects and
the identification of large numbers of families that could
be subjected to linkage studies, positional cloning, and
other molecular technologies (Stevenson and Schwartz
2002). The experience with Allan-Herndon-Dudley syn-
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drome (MIM 309600) is typical. Multigenerational fam-
ilies, beginning with the one reported in 1944 by Allan,
Herndon, and Dudley, have been identified on the basis
of childhood hypotonia, dysarthria, athetoid or other
distal limb movements, muscle hypoplasia, and severe
mental retardation (Allan et al. 1944; Bialer et al.
1992; Zorick et al. 2004). Linkage studies in several of
these families placed the gene in the interval Xq13-q21
(Schwartz et al. 1990; Bialer et al. 1992; Zorick et al.
2004). Identification of mutations in the monocarbox-
ylate transporter 8 gene (MCT8) in males with hypo-
tonia, involuntary movements, and mental retardation
made this gene an attractive candidate for Allan-Hern-
don-Dudley syndrome (Dumitrescu et al. 2004; Friesema
et al. 2004; Lenzner et al. 2004). Mutational analysis,
reported here for six families with Allan-Herndon-Dud-
ley syndrome, identified one truncating mutation, one
in-frame deletion, and four missense mutations in the
gene.
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Case Reports
Clinical findings for two families with Allan-Herndon-
Dudley syndrome have been reported elsewhere (kindred
8005 [K8005] by Allan et al. [1944] and Stevenson et
al. [1990] and K8090 by Davis et al. [1981] and Bialer
et al. [1992]). Clinical findings for K8225, K8900,
K9248, and K9251 are summarized below and in table
1. Pedigrees of the six kindreds are shown in figure 1.
K8005 had lived for many generations in North Caro-
lina and considered itself to be of Western European
white ancestry, K8090 was of Irish ancestry, K8225 was
white of uncertain ancestry, K8900 had lived for many
generations in Mississippi and was presumed to be of
Western European white ancestry, K9248 had mixed
American Indian (Cherokee) and Irish ancestry, and
K9251 was of Hispanic ancestry. High-resolution chro-
mosome analysis results, molecular FMR1 analysis re-
sults, and plasma amino acid levels were normal for at
least one affected male in each kindred. Results of clin-
ical testing of thyroid function are given in figure 2.
Although affected males were not frankly hypothyroid,
many did exhibit weakness, pale and cool skin, dry hair,
and constipation. None had prolonged neonatal jaun-
dice, macroglossia, umbilical hernia, or myxedema. Two
individuals (one in K8005 and one in K8900) had prom-
inent eyes. Among 16 carrier mothers, 4 had thyroid
disturbances: 3 had thyroid nodules in adult life, and 1
required treatment in adult life for hypothyroidism. With
the exception of one carrier female (III-2 in K8225) with
borderline low free thyroxine (T4) levels, the thyroid
hormone levels in carrier females ( ), noncarriernp 8
females ( ), and nonaffected males ( ) werenp 3 np 3
normal (table 2). Neuropsychological evaluation showed
all affected males to have severe cognitive impairment.
Adaptive skills were also severely impaired (table 3).
Carrier females have normal growth, appearance, and
intellectual function.
K8225
Five males from four generations of this family were
affected (fig. 1). The four living males, three obligate
female carriers, and six nonaffected males were evalu-
ated. Affected males are briefly described below, and
findings are summarized in table 1. Nonaffected males
and obligate female carriers had normal appearance,
normal muscle mass, and normal intellectual func-
tion. Linkage analysis localized the syndrome between
DXS983 (Xp11.3) and DXS101 (Xq22), with a maxi-
mum LOD score of 2.6 at DXS566 and DXS995 in
Xq13-q21 (data not shown).
IV-1 was evaluated at age 1 year. The pregnancy had
been complicated by maternal insulin-dependent dia-
betes mellitus. Delivery occurred at 39 wk, with a birth
weight of 3.8 kg (80th percentile) and length of 53.3 cm
(90th percentile). Respiratory and urinary tract infec-
tions occurred during the early months of life. Concern
arose regarding his development at age 6 mo, by which
time he showed poor feeding, general irritability, and
poor muscle tone and strength. At 1 year of age, his
measurements included a head circumference of 45.5 cm
(10th percentile), length of 75 cm (30th percentile), and
weight of 8.0 kg (!3rd percentile). The facies appeared
normal (fig. 3A). Neuromuscular findings included in-
adequate head control, decreased muscle tone and
strength, fisting, asymmetry of the thighs, eversion of the
feet, increased deep tendon reflexes at the knees, Babin-
ski signs, and exaggerated startle reflex.
III-3 was evaluated at age 28 years. His birth weight
was 3.2 kg (40th percentile), and his birth length was
53.3 cm (80th percentile). Development was always de-
layed; he never walked and had no speech. Examination
showed a head circumference of 54.7 cm (10th percen-
tile), height with scoliosis of 155 cm (!3rd percentile),
and weight of 30.8 kg (!3rd percentile). He was gen-
erally asthenic, and the head was held in a forward pos-
ture. The malar areas appeared prominent. Synophrys
and vertical furrowing of the brow were present (fig.
3C). The upper helices were excessively folded. Testes
were descended and of normal size. The hands were held
in a clubbed position with clasped thumb. Elbow move-
ment was restricted, scoliosis was present, and the hal-
luces appeared long. Deep tendon reflexes in all four
limbs were increased, and ankle clonus was present.
II-8 was evaluated at age 39 years. Birth weight was
3.6 kg (60th percentile). Development had always been
severely impaired. Examination showed a head circum-
ference of 57 cm (55th percentile), height of 165 cm (5th
percentile), and weight of 49.5 kg (!3rd percentile). The
facies appeared elongated, with prominent malar areas
(fig. 3D). Pectus excavatum was present. Testes were not
palpable. The hands were held in a clubbed position but
were not contracted. There was a general reduction of
muscle mass, and contractures were present at the knees.
III-11 was evaluated at age 14 years. His birth weight
was 4.1 kg (85 percentile), and his length was 53.3 cm
(80th percentile). Development was always severely de-
layed; he never walked or spoke. Seizures began at age
3 mo. His muscle mass was always poor. Examination
showed a head circumference of 53.5 cm (20th percen-
tile), length with contractures of 142 cm (!3rd percen-
tile), and weight of 21.4 kg (!3rd percentile). The face
appeared elongated and relatively expressionless (fig.
3B), and the palate was high. The right elbow was se-
verely contracted, and the left elbow was minimally con-
tracted. The right thumb was flexed, and the lower limbs
were held in valgus positioning, with contractures at the
knees and eversion of the feet. There was generalized
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Table 1
Summary of Clinical Findings for Six Families with Allan-Herndon-Dudley Syndrome
TRAIT
CLINICAL FINDING FOR FAMILYa
TOTALSK8005b K8090b K8225 K8900 K9248 K9251
Age range of individuals evaluated 25–71 y 30–76 y 1–39 y 2–16 y 22 mo–40 y 13–25 y …
No. of affecteds (no. of affecteds evaluated) 28 (12) 9 (8) 5 (4) 4 (2) 10 (4) 6 (2) 62 (32)
Head circumference !3rd percentile 0/12 0/8 0/4 1/2 2/4 NA 3/30 (10%)
Height !3rd percentile 0/6 0/8 2/4 2/2 0/4 NA 4/24 (17%)
Weight !3rd percentile 6/11 3/8 4/4 2/2 4/4 NA 19/29 (66%)
Hypotonia 12/12 8/8 2/2 1/1 4/4 2/2 29/29 (100%)
Asthenic build/muscle hypoplasia 9/12 7/8 4/4 2/2 4/4 2/2 28/32 (88%)
Narrow, long face 6/12 8/8 4/4 2/2 2/4 2/2 24/32 (75%)
Myopathic appearance 1/12 0/8 1/4 1/2 0/4 0/2 3/32 (9%)
Cupped/simple ears 5/12 4/8 1/4 1/2 1/4 0/2 12/32 (38%)
Scoliosis 2/12 7/8 3/4 1/2 2/4 2/2 17/32 (53%)
Pectus excavatum NA 6/8 1/4 0/1 2/4 2/2 11/19 (58%)
Contractures 7/12 4/8 3/4 1/2 2/4 2/2 19/32 (59%)
Hyperreflexia/clonus 12/12 7/8 3/4 2/2 4/4 2/2 30/32 (94%)
Dysarthria/limited speech 12/12 6/8 0/4 0/2 4/4 0/2 22/32 (69%)
Absent speech 0/12 2/8 4/4 2/2 0/4 2/2 10/32 (31%)
Nystagmus 0/10 0/4 0/4 0/2 0/4 0/2 0/26 (0%)
Ataxia and awkward gait 11/12 7/8 … … 0/4 … 18/30 (60%)
Never walked 1/12 1/8 4/4 2/2 4/4 0/2 12/32 (38%)
Valgus/everted feet NA 6/7 3/4 NA NA 1/2 10/13 (77%)
Abnormal hand positioning 10/12 6/8 4/4 1/2 4/4 1/2 26/32 (81%)
Undescended testes 0/9 0/7 1/3 0/2 1/4 NA 2/25 (8%)
Testis volume !10 ml 0/8 2/7 0/1 …c 1/1 NA 3/17 (18%)
Seizures 1/11 2/7 1/1 1/2 0/4 0/2 5/27 (19%)
a Data are no. of individuals with trait/total no. of individuals in kindred, unless otherwise specified. NA p data not available;
y p years.
b Clinical findings for K8005 were reported by Stevenson et al. (1990) and those for K8090 were reported by Bialer et al. (1992).
c Prepubertal at time of exam.
decreased muscle mass, increased bicep reflexes, and an-
kle clonus.
K8900
Two of the four affected males, four obligate carrier
females, and one nonaffected male from this family were
available for evaluation. Linkage analysis placed the
gene locus between DXS993 (Xp11.4) and DXS1002
(Xq21.31), with maximum LOD scores of 2.1 at
DXS1003 in Xp11.3, 2.0 at AR in Xq12, and 2.0 at
DXS986 in Xq21 (data not shown). Although initially
suspected of having thyroid-binding globulin (TBG) de-
ficiency, the TBG locus was excluded by these linkage
findings. By report from an older sister, II-6 and II-7
were severely disabled and never walked or spoke. They
had poor musculature and, in their later years, had
“twisting” of the hands and feet. They experienced dif-
ficulty swallowing, had little fine or gross motor control,
and had seizures. They appeared to see and hear; the
eyes were described as having a “wild and scared” ap-
pearance. II-6 died in his twenties, and II-7 died in his
thirties.
IV-3 weighed 3.6 kg (60th percentile) and was 52 cm
long (60th percentile) at birth. The pregnancy was no-
table for decreased fetal movement for a brief period at
7 mo. Cesarean delivery was performed because of
breech presentation. He appeared hypotonic and, by
age 2 years, could not sit unassisted, crawl, or pull up.
Examination showed generalized hypotonia, myopathic
face, asthenic build, broad and proximally placed thumbs,
transverse crease on the left hand, hyperreflexia, and
clonus. The serum T4 level was reported to be low, but
the specific value was not available. He died in his sleep
at age 7 years.
V-2 weighed 3.6 kg (60th percentile) at full-term birth.
Pregnancy was complicated by pneumonia and bron-
chiectasis. At age 1 h, he became cyanotic below the
neck for unknown reasons. Cranial CT at age 3 mo
showed ventricular enlargement with subdural fluid in
the frontal regions, findings considered to represent
brain atrophy. Seizures began at age 5 mo, and hypo-
thyroidism was diagnosed at age 9 mo. He sustained
several fractures attributed to osteoporosis. Examination
at age 16.5 years showed a head circumference of 53.8
cm (10th percentile), weight of 28 kg (!3rd percentile),
length with contractures of 127 cm (!3rd percentile),
inner canthal measurement of 2.8 cm (25th percentile),
and interpupillary measurement of 5.8 cm (50th per-
centile). He was alert and appeared to have some non-
verbal interaction with the examiner. He followed lights
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Figure 1 Partial pedigrees of six kindreds with Allan-Herndon-Dudley syndrome. Blackened squares indicate affected males, and hatched
squares indicate males with unrelated neurodevelopmental disorders.
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Figure 2 Serum levels of free T3 (top panel), free T4 (middle panel), and TSH (bottom panel) in affected males aged 0–5 years, 5–30
years, or 130 years from five of the six kindreds with Allan-Herndon-Dudley syndrome
and objects, but his capacity for hearing could not be
determined. His eyes were prominent but not proptotic.
Pinnae were simply formed, without folding of the su-
perior helices. A gastrostomy feeding tube was in place.
The limbs were poorly muscled, with contractures of the
lower limbs and increased deep tendon reflexes at the
left knee. The toes were held in clawed position, and the
hands in clubbed position, with intermittent limb hy-
perextension and limb athetoid movements. Genitalia
were prepubertal, and the testes were undescended. V-
2 died at age 22 years of aspiration pneumonia.
K9248
Ten males with severe mental retardation, childhood
hypotonia, and spastic paraplegia were from four gen-
erations of this white American Indian family. Four af-
fected males, five obligate female carriers, and one non-
affected male were examined. Affected males appeared
normal in growth and appearance at birth. Concerns
arose during the latter part of the first 6 mo, because of
failure to reach for objects and poor head control. There-
after, the developmental lag became more obvious, as
all motor and language milestones failed to occur on
schedule. Except for one carrier female who suffered
perinatal injury, all carrier females had normal intelli-
gence and normal growth, including head circumference,
and none had involuntary movements, hyperreflexia, or
other neurological signs. One affected individual died of
leukemia at 9 mo, one of pneumonia at age 32 years,
and one of unknown cause in early adult life. Linkage
analysis placed the gene locus distal to DXS453 in Xq13,
with no further recombination observed down to marker
DXS990 in Xq21.3, the most distal marker tested (data
not shown).
IV-5 was developmentally delayed from birth. He
developed speech that was limited to a few words or
phrases, beginning at age 2–3 years, and he never walked.
Examination at age 40 years showed a head circumfer-
ence of 54.3 cm (5th percentile), length with contractures
of 185 cm (90th percentile), and weight of 58 kg (!3rd
percentile). The face was elongated, with midface hy-
poplasia, narrow high palate, anteverted nares, spaced
teeth, and square face (fig. 4D). The chest wall was
asymmetric. Testes were undescended. Muscle tone and
deep tendon reflexes were increased, more so in the
lower limbs than in the upper limbs. Dysarthria, scoli-
osis, lower-limb scissoring, knee contractures, wrist flex-
ion, and athetoid posturing of the hands were present.
IV-6 never walked and developed only limited speech.
At age 38 years, his head circumference was 55.4 cm
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Table 2
Thyroid Hormone Levels in Carrier Females, Noncarrier Females,
and Nonaffected Males
Subjects, Kindred,
and Individual
Total T4
(mcg/dl)
Free T4
(ng/dl)
Total T3
(ng/dl)
Free T3
(pg/dl)
TSH
(mIU/ml)
Carrier females:
K8090:
III-4 … 1.08 … 320 1.5
K8225:
III-2 … .8 … 286 1.5
K8900:
II-3 … 1.1 114 … …
II-8 … .9 110 … …
III-7 … 1.0 134 … …
IV-2 … 1.2 126 … …
K9248:
IV-12 5.88 1.01 … 310 1.6
IV-16 8.07 1.02 … 290 1.8
Noncarrier females:
K8900:
NSa … 1.0 114 … …
II-5 … 1.1 94 … …
III-6 … 1.0 106 … …
Nonaffected males:
K8005:
VI-26 5.9 .86 … … 2.6
K8900:
V-1 … 1.2 154 … …
K9248:
V-7 10.3 1.23 … 410 1.2
NOTE.—Normal ranges are as follows: total T4, 4.5–12.5 mcg/dl; free T4,
0.8–1.8 ng/dl; total T3, 60–181 ng/dl; free T3, 230–420 pg/dl; and TSH, 0.4–
5.5 mIU/ml.
a Noncarrier female not shown in abbreviated pedigree of K8900 in figure 1.
(20th percentile), height with contractures was 177 cm
(60th percentile), and weight was 45 kg (!3rd percen-
tile). A widow’s peak was present, and the midface was
hypoplastic, with high and narrow palate, widely spaced
teeth, and square jaw (fig. 4C). Truncal hypotonia, pec-
tus excavatum, scoliosis, decreased lower-limb muscu-
lature, increased limb muscle tone and deep tendon
reflexes, knee contractures, wrist flexion, and hand ath-
etoid posturing were present.
V-6 weighed 3.4 kg (45th percentile), measured 51 cm
in length (50th percentile), and had a head circumference
of 34.6 cm (40th percentile) at term birth. Hypotonia
and poor head control were obvious by age 6 mo. He
rolled over at age 3 years and, by age 5 years, could not
sit, pull up, or walk and had speech limited to 3–6
words. Examination at age 5 years showed a head cir-
cumference of 48.2 cm (!3rd percentile), length of 108
cm (50th percentile), and weight of 14.8 kg (!3rd per-
centile). He has amblyopia and myopia, cupped ears,
anteverted nares, tenting of the upper lip, narrow tall
palate, normal prepubertal genitalia, and a straight spine
(fig. 4B). He also has truncal hypotonia, poor head con-
trol, increased limb tone and deep tendon reflexes, in-
termittent internal rotation of the arms, elbow hyper-
extension, and ankle clonus.
V-3 had a weight of 3.5 kg (50th percentile), length
of 48 cm (10th percentile), and head circumference of
35.5 cm (55th percentile) at birth. At ∼6 mo of age, he
was noted to have poor muscle tone, poor head control,
and limited use of hands. He began rolling over at age
3–4 months but, at age 22 mo, could not sit, pull up,
or crawl. Athetoid hand posturing was noted at age 5
mo. Although he said his first words at age 1 year, further
speech development has been very limited. At age 22
mo, he had a head circumference of 46.5 cm (!3rd per-
centile), length of 84 cm (25th percentile), and weight
of 9.7 kg (!3rd percentile). Facial features included de-
pressed nasal bridge, anteverted nares, short philtrum,
tented upper lip, and low-set and posteriorly rotated ears
(fig. 4A). He had truncal hypotonia, limb hypertonia and
hyperreflexia, upper-limb athetoid posturing, and lower-
limb scissoring. Genitalia appeared normal.
K9251
Five males were affected in three generations of this
family from Argentina. Three of those presumed to be
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Table 3
Cognitive Function and Adaptive Behaviors
KINDRED AND
INDIVIDUAL AGE IQa,b
ADAPTIVE SKILL LEVELb
(years/mo)
Communication Daily Living Socialization
K8225:
II-8 51 years !20 0/11 1/1 0/11
III-3 28 years !20 … NA …
III-11 14 years !20 … NA …
IV-1 13 years NA 1/5 1/6 2/3
K8900:
V-2 13 years !20 0/11 0/10 0/11
K9248:
IV-5 40 years !20 1/3 1/56 1/2
IV-6 38 years !20 0/11 1/4 0/8
V-6 5 years 24 1/0 0/11 0/9
V-3 22 mo NA 0/6 0/9 0/9
K9251:
II-4 25 years !30 … NA …
III-2 13 years !30 … NA …
a IQ scores are based on testing with the Stanford-Binet. IQ test results for K8005
and K8090 were reported by Stevenson et al. (1990) and Bialer et al. (1992), respectively.
b NA p information not available.
affected were deceased. I-5 and I-6 were diagnosed with
hypotonic cerebral palsy. II-14 died at age 7 mo, with
global developmental delay. Because the phenotype was
consistent with Allan-Herndon-Dudley syndrome, link-
age analysis was omitted, and mutational analysis of
MCT8 was pursued.
II-4 had lifelong global delay, truncal hypotonia, poor
head control, and limited motor skills. He had facial
elongation, pectus excavatum, scoliosis, hyperreflexia,
cavus feet, and contractures of the fingers, knees, and
ankles. He has severe mental retardation and cannot
walk or speak.
III-2 was born at term by Cesarean delivery and
weighed 4.3 kg (90th percentile). Fetal movements were
diminished during the last months of pregnancy. From
birth, he exhibited truncal hypotonia and delayed de-
velopment. At age 13 years, he showed poor control of
the head and trunk, elongation of the face, mental re-
tardation, and absence of speech and independent am-
bulation. He had scoliosis and dorsal kyphosis, pectus
excavatum, contractures at the knees and ankles, and
hyperreflexia. Nerve conduction; findings of electro-
myography, electroencephalography, muscle biopsy, and
brain MRI; and levels of creatine kinase, plasma amino
acids, and urine oligosaccharides and mucopolysaccha-
rides were normal. Cranial CT showed cortical and sub-
cortical atrophy.
II-12 is considered to have an unrelated neuromotor
disorder, having no symptoms until age 15 years, when
he developed difficulty in running and walking up stairs.
He lost fine and gross motor skills and, at age 27 years,
had distal muscle atrophy, cavus feet, and hyperreflexia.
His mother had normal results for MCT8 mutational
analysis.
Methods
Consent
Informed consent was obtained from the parent(s) or
guardian(s) of the affected individuals by use of the con-
sent form approved by the Self Regional Healthcare In-
stitutional Review Committee.
Preparation of DNA
Genomic DNA was prepared using a high-salt pre-
cipitation method with peripheral blood (Schwartz et al.
1990). The purified genomic DNA was diluted to 105
mg/ml and was stored at 4C.
PCR
All exons were amplified individually. The primers,
sizes, and annealing temperatures are available in table
4. All primers were tailed with M13 primers to facilitate
sequencing. All exons were amplified using a PTC-200
thermocycler (MJ Research), with a total volume of 60
ml containing 1# PCR buffer with 1 mM of each primer,
0.08 mM dNTPs, and 0.02 U of GoTaq DNA poly-
merase (Promega).
Sequencing Analysis
PCR fragments for each exon were sequenced in both
directions on the MegaBACE (Amersham Biosciences)
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Figure 3 Appearance of four affected males in K8225. A, IV-1
at age 1 year, showing a normal face. B, III-11 at age 14 years, showing
an elongated and myopathic face. C, III-3 at age 28 years, showing
synophrys and prominence of the lower lip. D, II-8 at age 39 years,
showing an elongated face with prominence of malar areas and an
open mouth.
Table 4
Sequences, Sizes, and Annealing Temperatures of
Primers Used to Analyze the Exons and Adjacent
Intron Sequences of MCT8
The table is available in its entirety in the online edition
of The American Journal of Human Genetics.
by use of the M13 forward and reverse primers, in ac-
cordance with the manufacturer’s protocol. The align-
ment and analysis of the sequences were done using the
DNASTAR program (Lasergene).
Denaturing High-Pressure Liquid Chromatography
Analysis
Mutations in exons 1, 2, and 4 were subjected to
heteroduplex analysis for segregation studies in the fam-
ilies and for screening in a cohort of normal males. To
ensure proper formation of duplex DNA, the PCR prod-
uct obtained from the proband or family member was
mixed with an equal volume of PCR product from a
control individual. The samples were denatured at 95C
for 12 min and were allowed to renature for 45 min by
decreasing the temperature from 95C to 25C. For the
normal male cohort, pools of four individuals were cre-
ated for analysis after PCR amplification of each indi-
vidual. Amplicons were analyzed on the WAVE DNA
fragment analysis system equipped with DNA Sep col-
umn (Transgenomic), at the following temperatures:
exon 1, 61C; exon 2, 60C and 63C; and exon 4,
59.7C and 60.5C.
Ear1 Digestion of Exon 6 Amplicon
The mutation that was found in exon 6 destroyed an
Ear1 restriction site. Digestion was performed using 10
ml of a PCR product generated using primers for exon
6 in a total reaction volume of 20 ml. The reaction mix
contained 1# NEBuffer 1, 1# spermidine, and 0.25 ml
Ear1 enzyme (NEB). The digestion occurred overnight
at 37C, and the products were analyzed on a 2% aga-
rose gel. Ear1 digested the 395-bp product from the
proband of K8005 into 2 fragments of 328 bp and 67
bp. A normal individual has three fragments after Ear1
digestion: 155 bp, 173 bp, and 67 bp.
Computational Analysis of Altered MCT8 Proteins
Estimation of the effect of a mutation in MCT8 at the
protein level was done using the Protean software avail-
able in DNASTAR (Lasergene).
Results
Direct genomic sequencing of the six exons of MCT8,
plus 80 bp of flanking sequence on either side of the
exons, detected alterations in all six kindreds with Allan-
Herndon-Dudley syndrome (table 5). One mutation was
truncating, one was an in-frame deletion, and four were
missense. In K8900, a truncating mutation (p.S448X)
was identified. The creation of the novel stop codon
results in the protein missing the last four transmem-
brane domains (TMDs) as well as the carboxyl cyto-
plasmic end of the protein. K9251 was found to have
an in-frame 3-bp deletion, c.683delTCT, which removes
a phenylalanine at position 230 (delF230). This resi-
due is the first of two phenylalanines in the middle of
the second TMD and is highly conserved. In K8225,
base substitution c.703GrA causes missense mutation
p.V235M in the second TMD. This valine is highly con-
served when compared to mouse and rat. Additionally,
the presence of this methionine may create a novel ini-
tiation site. However, this possibility could not be ex-
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Figure 4 Appearance of four affected males in K9248. A, V-3
at age 22 mo, showing a cupped left ear, depressed nasal bridge, widely
anteverted nares, and tenting of the upper lip with short philtrum. B,
V-6 at age 5 years, showing incomplete folding of superior helices and
short philtrum. C, IV-6 at age 38 years, showing elongated face with
widow’s peak, flattening of midface, and square jaw. D, IV-5 at age
40 years, showing a long face with short philtrum.
Table 5
MCT8 Mutations in Allan-Herndon-Dudley
Syndrome
Kindred Mutation
Amino Acid
Change
K8005 c.1703TrC (exon 6) L568P
K8090 c.1301TrG (exon 4) L434W
K8225 c.703GrA (exon 2) V235M
K8900 c.1343CrA (exon 4) S448X
K9248 c.581CrT (exon 1) S194F
K9251 c.683delTCT (exon 2) delF230
amined further, because MCT8 is not transcribed in
lymphocytes, the only tissue available for analysis.
The second missense mutation, p.L434W in K8090,
occurs in the eighth TMD. This leucine is highly con-
served when compared to mouse and rat. In K8005, a
c.1703TrC substitution produces missense mutation
p.L568P. As with the p.L434W missense mutation, a
highly conserved leucine residue is altered, this time in
the twelfth TMD. The fourth missense mutation was
found in K9248, resulting in a S194F change in the first
extracellular domain between the first and second
TMDs. None of these six mutations in MCT8 was found
in 470 normal male controls.
Discussion
Spastic paraplegia is among the more common of the
clinical findings that co-occur with X-linked mental re-
tardation. Spastic paraplegia 1 is part of the X-linked
hydrocephaly spectrum caused by mutations in L1CAM
(Vits et al. 1994). Spastic paraplegia 2 is the dominant
clinical presentation of Pelizaeus-Merzbacher syndrome,
caused by mutations in PLP (Saugier-Veber et al. 1994).
In addition, spastic paraplegia is a prominent finding in
23 other X-linked mental retardation (XLMR) syn-
dromes (Stevenson et al. 2000) (table 6). The progression
to spastic paraplegia in the Allan-Herndon-Dudley syn-
drome is notable. From infancy into early childhood,
hypotonia and decreased muscle mass dominate the neu-
romuscular findings. Hypotonia and weakness is partic-
ularly notable in the neck muscles. Truncal hypotonia
persists into adult life. There is a transition in child-
hood to spasticity manifested by hyperreflexia at the
large joints, clonus, and Babinski signs. Contractures
commonly occur. Involuntary movements of the distal
limbs, dystonic and/or athetoid in nature, occur in
most affected individuals. Virtually all affected males
become wheelchair bound in adult life, although many
had achieved independent but delayed and unsteady
ambulation.
In all affected males with available records, intra-
uterine growth was normal. In early childhood, weight
typically fell below the 3rd percentile and remained
there. Length during childhood was usually normal;
measurement of adult length was compromised by sco-
liosis and contractures, commonly measuring !3rd per-
centile. Occipitofrontal head circumference usually fell
below average, but in only two instances were mea-
surements !3rd percentile recorded (table 1).
The development of all 32 affected males who were
evaluated was severely impaired from birth. None de-
veloped normal speech: 10 had no speech, and 22 had
limited and/or severely dysarthric speech. Twelve males
never ambulated independently. Ambulation was mark-
edly delayed among those who learned to walk and was
lost by adult life.
Compatibility with longevity was evident by the 8
affected males, of the 32 evaluated, who lived beyond
70 years. This notwithstanding, the family histories in-
dicated that three affected males died before age 10
years, one died during the teen years, two died during
their twenties, and four died during their thirties.
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Table 6
X-Linked Syndromes with Spastic Paraplegia as a Major Phenotypic Manifestation
Syndrome Gene Locusa Gene (If Known)
Adrenoleukodystrophy Xq28 ABCD1
Allan-Herndon-Dudley Xq21 MCT8
Apak ataxia–spastic paraplegia (cerebellar ataxia 2) Xp11.21-q21.3
Arena Xq22–25
Ataxia-deafness (Schmidley) NL
Brooks-Wisniewski-Brown NL
Christianson Xq24-q27.3
Fitzsimmons NL
Gustavsson Xq26
Kang NL
Lesch-Nyhan Xq26-q27.2 HPRT1
Miles-Carpenter Xq13-q22
Mohr-Tranebjaerg (Jensen) Xq22 TIMM8A
Paine-Seemanova NL
Pallister W NL
Pelizaeus-Merzbacher (spastic paraplegia, type 2) Xq22 PLP1
Pettigrew Xq25-Xq27
Psychosis–pyramidal signs–macroorchidism, X-linked Xq28 MECP2
Proud Xp22 ARX
Rett Xq28 MECP2
Schimke NL
X-linked hydrocephalus spectrum (spastic paraplegia, type 1) Xq28 L1CAM
X-linked lissencephaly Xq22.3-q23 DCX
XLMR-blindness-seizures-spasticity (Hamel) Xp11.3-q12
XLMR-hydrocephaly–basal ganglia calcifications (Fried) Xp22
XLMR-hypotonia–recurrent infections (Lubs) Xq28
a NL p not localized.
Cognitive impairment in affected males was severe.
Since most affected males were unable to meet the
baseline of standardized cognitive tests, the precise level
of mental retardation could not be determined (table
3). There was no evidence of an unusual cognitive
strength—the neuropsychological profile was generally
flat, except for the fact that the subjects were remark-
ably affable and tuned into social interactions, which
was even more remarkable because of the significant
motor and cognitive handicaps. Because of the severity
of cognitive impairment, some patients were evaluated
with only the Vineland Adaptive Behavior Scale–Inter-
view Edition (table 3).
The pattern of findings in these families with Allan-
Herndon-Dudley syndrome is the same as that in 10
other individuals/families with the MCT8 mutation
reported by Dumitrescu et al. (2004), Friesema et al.
(2004), and Lenzner et al. (2004). Hypotonia in infancy
and early childhood was accompanied by motor, speech,
and mental delays and was followed by development of
spasticity, dystonia, and other involuntary distal hand
movements. Dumitrescu et al. (2004) reported rotary
nystagmus, disconjugate eye movements, and feeding
difficulties in two affected boys from different kindreds,
findings that were not noted in the other reports or in
the families with Allan-Herndon-Dudley syndrome.
Assessments of thyroid function in males with Allan-
Herndon-Dudley syndrome showed, in most cases, high
free triiodothyronine (T3) and low free T4 levels in se-
rum (fig. 2). Serum TSH levels were normal. The alter-
ations in free T3 and free T4 levels provide a convenient
method of selecting males for MCT8 mutational studies.
Since an elevated free T3 level in serum is found more
consistently than is a low free T4 level (fig. 2), mea-
surement of serum free T3 levels would be the preferred
method for screening high-risk populations, such as
children with developmental delay and hypotonia.
The paucity of findings that suggest a disturbance in
thyroid metabolism is perplexing. Specifically, affected
males fail to show the somatic findings typical of hy-
pothyroidism, such as prolonged neonatal jaundice,
myxedematous skin changes, macroglossia, hoarseness,
and umbilical hernias. Statural growth may be stunted
but not as notably as in hypothyroidism. The overall
weakness, pale cool skin, dry hair, and constipation in
a number of affected males may be related to decreased
thyroid-hormone availability to some tissues. Two af-
fected males had prominent eyes, a finding suggestive
of endocrine ophthalmopathy or thyrotoxicosis. Al-
though the repertoire of molecules transported by the
monocarboxylate transporter 8 is not known, the ab-
normal transport of another molecule essential to neu-
rons cannot be ruled out as the disease-causing event
(Friesema et al. 2005). Nonetheless, the perturbations
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in T3 and T4 levels may serve as useful biomarkers to
screen for Allan-Herndon-Dudley syndrome.
It is tempting to speculate that dietary supplemen-
tation with T4 or T3 might be beneficial. To date, at-
tempts at therapy with thyroxine administrated during
infancy in two cases were unsuccessful in ameliorating
the neurological signs (Dumitrescu et al. 2004).
Among the six novel mutations in MCT8 reported
here, one (p.S448X) truncates the protein near the end
of the eighth TMD, removing the last four TMDs and
the cytoplasmic region at the carboxy end of the protein.
Another mutation was an in-frame deletion of 3 bp
resulting in the removal of one of two adjacent phen-
ylalanines (del F230) in the second TMD. This is pre-
dicted to remove a turn region and extend a b-sheet
region.
Three missense mutations (V235M, L434W, and
L568P) occur in other TMDs of the MCT8 protein.
Each alters a highly conserved residue in their respective
TMD. The V235M missense alteration is predicted to
substitute a coil region and an alpha helix where a turn
region would normally exist in the second TMD. The
L434W missense mutation in the eighth TMD shortens
a prominent b-sheet region and lengthens a coil region.
The L568P missense mutation in the last TMD results
in the formation of a small beta amphipathic region
followed by a small alpha amphipatic region near the
cytoplasmic region of the TMD and the removal of a
short coil section at the end of the TMD. A fourth
missense mutation, S194F, occurs within the first ex-
tracellular region of the protein, between the first and
second TMDs. This alteration would appear to elimi-
nate a b-sheet region, forming a coiled region instead.
The prevalence of MCT8 mutations as a cause of
XLMR is not known. With the rapid identification of
mutations in 16 families (Dumitrescu et al. 2004; Frie-
sema et al. 2004: Lenzner et al. 2004; the present study),
it is possible that MCT8 mutations may number among
the more prevalent mutations on the X chromosome
(e.g., mutations in FMR1, MECP2, RSK2, ARX, and
L1CAM) that cause mental retardation. Studies of other
families with XLMR linked to Xq13.2 and sporadic
males with mental retardation will be necessary to de-
termine the prevalence.
Expression in females is doubtful but has not been
studied systematically or longitudinally. Dumitrescu et
al. (2004) noted that some carrier females have abnor-
mal thyroid hormone tests. Four of 16 carrier females
in the six families with Allan-Herndon-Dudley syn-
drome reported a history of thyroid disease. Three had
thyroid nodules in adult life, and one had hypothy-
roidism. Both thyroid nodules and hypothyroidism
are common thyroid-related findings in adults. One
carrier female (III-2 in K8225) had borderline low free
T4 levels, and seven other carrier females had normal
thyroid hormone levels (table 2). X-inactivation studies
in 20 female gene carriers, aged 18–78 years, from the
six kindreds with Allan-Herndon-Dudley syndrome
showed no consistent pattern. Only one carrier had
markedly skewed X-inactivation (190% of cells having
the same X chromosome active).
With the identification of mutations in MCT8 as re-
sponsible for Allan-Herndon-Dudley syndrome, the
gene defects have been found for all XLMR syndromes
described before fragile X syndrome (Lubs 1969). Three
of the early reports were descriptions of fragile X syn-
drome mutation in FMR1, as later confirmed by cyto-
genetic and molecular testing in each of these families
(Martin and Bell 1943; Losowsky 1961; Dunn et al.
1962–1963). Other XLMR syndromes described be-
tween 1868 and 1969 for which the gene defect is
known include Duchenne muscular dystrophy (DMD),
Pelizaeus-Merzbacher syndrome (PLD), dyskeratosis
congenita (DKC), Hunter syndrome (IDS), incontinen-
tia pigmenti (NEMO), Norrie panophthalmia syndrome
(NDP), X-linked hydrocephaly spectrum (L1CAM),
Renpenning syndrome (PQBP1), and Snyder-Robinson
syndrome (SMS). This is indicative of the progress in
the molecular delineation of XLMR syndromes. Among
165 XLMR syndromes, the responsible gene has been
identified in 78 syndromes, regional mapping has been
achieved for an additional 53 syndromes, and 34 syn-
dromes have not been mapped.
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